Penumbra Inc (PEN)

$237.94 -5.93 (-2.43%)
Market Cap 9.44B
Revenue (ttm) 1.19B
Net Income (ttm) 14.01M
EPS (ttm) N/A
PE Ratio 74.28
Forward PE 65.73
Profit Margin 1.17%
Debt to Equity Ratio 0.00
Volume 377,300
Avg Vol 486,940
Day's Range N/A - N/A
Shares Out 38.73M
Stochastic %K 8%
Beta 0.47
Analysts Strong Sell
Price Target $318.62

Company Profile

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under...

Industry: Medical Devices
Sector: Healthcare
Phone: 510 748 3200
Address:
One Penumbra Place, Alameda, United States
yaydeezie
yaydeezie Jul. 11 at 2:58 PM
$PEN why is this stock dropping? 👀🙄
0 · Reply
JarvisFlow
JarvisFlow Jul. 9 at 7:17 PM
Citigroup has updated their rating for Penumbra ( $PEN ) to Neutral with a price target of 285.
0 · Reply
NVDAMillionaire
NVDAMillionaire Jul. 7 at 11:32 AM
$PEN Excellent article that nails exactly where PEN stands right now. So if you want to update your PEN knowledge or get acquainted with PEN, this is a must read. https://beyondspx.com/article/penumbra-cavt-innovation-fuels-growth-and-profitability-expansion-nyse-pen
0 · Reply
JarvisFlow
JarvisFlow Jun. 20 at 10:30 AM
RBC Capital updates rating for Penumbra ( $PEN ) to Outperform, target set at 232 → 285.
0 · Reply
JarvisFlow
JarvisFlow Jun. 20 at 10:30 AM
RBC Capital has updated their rating for Penumbra ( $PEN ) to Outperform with a price target of 232.
0 · Reply
StreetwiseReports
StreetwiseReports Jun. 17 at 9:32 PM
Exploration Firms Seize Opportunity Amid Global Oil Reset https://ow.ly/gQLs50Wb8fA Jericho Energy Ventures Inc., Panoro Energy ASA, and Ring Energy Inc. pursue bold strategies to unlock value from powering AI data centers to boosting reserves and expanding U.S. shale production. Read more to see how each company is adapting to shifting oil market dynamics and long-term energy trends. $JEV.V $JROOF $PEN:OSE $REI
0 · Reply
Looking4Bargain
Looking4Bargain Jun. 14 at 7:37 PM
$PEN Price keeps this way I see this as a ~$320 buyout. Same fate as $SWAV.
0 · Reply
ZacksResearch
ZacksResearch Jun. 9 at 2:55 PM
$PEN launches Ruby XL System — what’s next for the stock? PEN is expanding its peripheral embolization portfolio with the Ruby XL System, aiming to enhance efficiency and outcomes while reducing radiation exposure. The positive market sentiment is expected to continue with PEN's anticipated 67.6% earnings increase by 2025 according to the Zacks Consensus Estimate. Discover more about PEN's growth potential here 👉 https://www.zacks.com/commentary/2490510/pen-stock-rises-following-the-launch-of-ruby-xl-system?cid=sm-stocktwits-2-2490510-body&ADID=SYND_STOCKTWITS_TWEET_2_2490510_BODY
0 · Reply
ZacksResearch
ZacksResearch Jun. 9 at 12:07 PM
$PEN pops on new product launch — is this the next growth driver? The FDA-cleared Ruby XL System brings advanced coil tech to high-flow embolization, expanding Penumbra’s vascular solutions lineup. Full breakdown of the launch here 👉 https://www.zacks.com/stock/news/2490510/pen-stock-rises-following-the-launch-of-ruby-xl-system?cid=sm-stocktwits-2-2490510-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2490510_TEASER
0 · Reply
TalkMarkets
TalkMarkets Jun. 8 at 7:20 PM
3 Medical Instruments Stocks Winning Big With GenAI Amid Global Gloom $ANGO $ITGR $PEN https://talkmarkets.com/content/stocks--equities/3-medical-instruments-stocks-winning-big-with-genai-amid-global-gloom?post=501843&userid=123969
0 · Reply
Latest News on PEN
Penumbra, Inc. Schedules Second Quarter 2025 Earnings Release and Conference Call for July 29, 2025

Jul 1, 2025, 4:30 PM EDT - 10 days ago

Penumbra, Inc. Schedules Second Quarter 2025 Earnings Release and Conference Call for July 29, 2025

Penumbra: AI Meets Aspiration - Why The Stock Is A Structural Winner

Jun 26, 2025, 6:00 AM EDT - 16 days ago

Penumbra: AI Meets Aspiration - Why The Stock Is A Structural Winner

Penumbra, Inc. Announces Completion of Enrollment for Landmark STORM-PE Randomized Controlled Trial

Jun 16, 2025, 9:00 AM EDT - 26 days ago

Penumbra, Inc. Announces Completion of Enrollment for Landmark STORM-PE Randomized Controlled Trial

Penumbra Introduces the Ruby® XL System - the Longest, Largest, and Softest Coil on the Market for Vascular Embolization

Jun 5, 2025, 9:00 AM EDT - 5 weeks ago

Penumbra Introduces the Ruby® XL System - the Longest, Largest, and Softest Coil on the Market for Vascular Embolization

Penumbra, Inc. to Present at Upcoming Investor Conferences

May 20, 2025, 4:30 PM EDT - 7 weeks ago

Penumbra, Inc. to Present at Upcoming Investor Conferences

Penumbra, Inc. to Present at the BofA Securities 2025 Health Care Conference

Apr 29, 2025, 4:30 PM EDT - 2 months ago

Penumbra, Inc. to Present at the BofA Securities 2025 Health Care Conference

Baron Health Care Fund Q1 2025 Top Net Purchases And Sales

Apr 29, 2025, 11:45 AM EDT - 2 months ago

Baron Health Care Fund Q1 2025 Top Net Purchases And Sales

ACLX ISRG MASI MCK NTRA TMO UNH

Penumbra Among Well-Insulated Companies From Ongoing Tariff Dynamics, Says Analyst

Apr 24, 2025, 3:27 PM EDT - 2 months ago

Penumbra Among Well-Insulated Companies From Ongoing Tariff Dynamics, Says Analyst

Penumbra, Inc. (PEN) Q1 2025 Earnings Call Transcript

Apr 23, 2025, 8:15 PM EDT - 2 months ago

Penumbra, Inc. (PEN) Q1 2025 Earnings Call Transcript

Penumbra, Inc. Reports First Quarter 2025 Financial Results

Apr 23, 2025, 4:05 PM EDT - 2 months ago

Penumbra, Inc. Reports First Quarter 2025 Financial Results

Penumbra, Inc. Schedules First Quarter 2025 Earnings Release and Conference Call for April 23, 2025

Apr 3, 2025, 4:30 PM EDT - 3 months ago

Penumbra, Inc. Schedules First Quarter 2025 Earnings Release and Conference Call for April 23, 2025

Seven New Data Sets Demonstrate Penumbra's Computer Assisted Vacuum Thrombectomy (CAVT) Technology Is Safe, Fast and Effective, Improves Patient Outcomes, and Delivers Healthcare Resource Benefits

Apr 2, 2025, 9:00 AM EDT - 3 months ago

Seven New Data Sets Demonstrate Penumbra's Computer Assisted Vacuum Thrombectomy (CAVT) Technology Is Safe, Fast and Effective, Improves Patient Outcomes, and Delivers Healthcare Resource Benefits

Penumbra, Inc. Announces Don Kassing will Retire from Board of Directors

Feb 21, 2025, 4:05 PM EST - 5 months ago

Penumbra, Inc. Announces Don Kassing will Retire from Board of Directors

Stroke Device Maker Penumbra Stock Surges On Earnings Beat, Analysts Boost Price Forecasts After Upbeat 2025 Outlook

Feb 19, 2025, 4:03 PM EST - 5 months ago

Stroke Device Maker Penumbra Stock Surges On Earnings Beat, Analysts Boost Price Forecasts After Upbeat 2025 Outlook

Penumbra, Inc. (PEN) Q4 2024 Earnings Call Transcript

Feb 18, 2025, 11:04 PM EST - 5 months ago

Penumbra, Inc. (PEN) Q4 2024 Earnings Call Transcript

Penumbra, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 18, 2025, 4:05 PM EST - 5 months ago

Penumbra, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results

Penumbra, Inc. Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call for February 18, 2025

Jan 21, 2025, 4:30 PM EST - 6 months ago

Penumbra, Inc. Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call for February 18, 2025

Penumbra, Inc. to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Dec 30, 2024, 4:30 PM EST - 6 months ago

Penumbra, Inc. to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Penumbra Is Poised For Growth As Blood Clot Awareness Rises: Analyst

Dec 17, 2024, 11:03 AM EST - 7 months ago

Penumbra Is Poised For Growth As Blood Clot Awareness Rises: Analyst

Penumbra, Inc. to Present at the Piper Sandler 36th Annual Healthcare Conference

Nov 20, 2024, 4:30 PM EST - 8 months ago

Penumbra, Inc. to Present at the Piper Sandler 36th Annual Healthcare Conference

New Late Breaking Data Show Patients Treated with Penumbra's Computer Assisted Vacuum Thrombectomy Technology for Pulmonary Embolism Experience Shorter Hospital Stays and Fewer Complications Compared to Other Treatment Options

Nov 5, 2024, 9:00 AM EST - 8 months ago

New Late Breaking Data Show Patients Treated with Penumbra's Computer Assisted Vacuum Thrombectomy Technology for Pulmonary Embolism Experience Shorter Hospital Stays and Fewer Complications Compared to Other Treatment Options

Penumbra, Inc. (PEN) Q3 2024 Earnings Call Transcript

Oct 30, 2024, 11:45 PM EDT - 9 months ago

Penumbra, Inc. (PEN) Q3 2024 Earnings Call Transcript

Penumbra, Inc. Reports Third Quarter 2024 Financial Results

Oct 30, 2024, 4:05 PM EDT - 9 months ago

Penumbra, Inc. Reports Third Quarter 2024 Financial Results

Penumbra, Inc. Announces Completion of THUNDER IDE Study Enrollment for Acute Ischemic Stroke

Oct 14, 2024, 9:00 AM EDT - 9 months ago

Penumbra, Inc. Announces Completion of THUNDER IDE Study Enrollment for Acute Ischemic Stroke

Penumbra, Inc. Schedules Third Quarter 2024 Earnings Release and Conference Call for October 30, 2024

Oct 2, 2024, 4:30 PM EDT - 10 months ago

Penumbra, Inc. Schedules Third Quarter 2024 Earnings Release and Conference Call for October 30, 2024

Penumbra Receives CE Mark for Computer Assisted Vacuum Thrombectomy Technologies - Lightning Flashâ„¢ 2.0 and Lightning Boltâ„¢ 7 - in Europe

Sep 16, 2024, 3:00 AM EDT - 10 months ago

Penumbra Receives CE Mark for Computer Assisted Vacuum Thrombectomy Technologies - Lightning Flashâ„¢ 2.0 and Lightning Boltâ„¢ 7 - in Europe

Penumbra, Inc. to Present at the Baird Global Healthcare Conference

Aug 27, 2024, 4:30 PM EDT - 11 months ago

Penumbra, Inc. to Present at the Baird Global Healthcare Conference

Penumbra, Inc. to Present at the Wells Fargo Healthcare Conference

Aug 21, 2024, 4:30 PM EDT - 11 months ago

Penumbra, Inc. to Present at the Wells Fargo Healthcare Conference

Penumbra: Growth In Its Thrombectomy Portfolio Should Lead To Strong Earnings

Aug 19, 2024, 9:28 PM EDT - 11 months ago

Penumbra: Growth In Its Thrombectomy Portfolio Should Lead To Strong Earnings

Penumbra, Inc. Announces $200 Million Share Repurchase Authorization

Aug 13, 2024, 7:00 AM EDT - 11 months ago

Penumbra, Inc. Announces $200 Million Share Repurchase Authorization

Penumbra, Inc. to Present at the Canaccord Genuity Growth Conference

Aug 2, 2024, 4:30 PM EDT - 1 year ago

Penumbra, Inc. to Present at the Canaccord Genuity Growth Conference

Penumbra, Inc. (PEN) Q2 2024 Earnings Call Transcript

Jul 30, 2024, 7:25 PM EDT - 1 year ago

Penumbra, Inc. (PEN) Q2 2024 Earnings Call Transcript

Penumbra, Inc. Reports Second Quarter 2024 Financial Results

Jul 30, 2024, 4:05 PM EDT - 1 year ago

Penumbra, Inc. Reports Second Quarter 2024 Financial Results

Penumbra, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call for July 30, 2024

Jul 2, 2024, 4:05 PM EDT - 1 year ago

Penumbra, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call for July 30, 2024

Top 3 Health Care Stocks That Could Blast Off In June

Jun 21, 2024, 8:22 AM EDT - 1 year ago

Top 3 Health Care Stocks That Could Blast Off In June

ENOV RGEN

Penumbra, Inc. to Present at the Truist Securities MedTech Conference

Jun 4, 2024, 4:30 PM EDT - 1 year ago

Penumbra, Inc. to Present at the Truist Securities MedTech Conference

Penumbra, Inc. to Present at the William Blair Growth Stock Conference

May 23, 2024, 4:30 PM EDT - 1 year ago

Penumbra, Inc. to Present at the William Blair Growth Stock Conference

Penumbra, Inc. (PEN) Q1 2024 Earnings Call Transcript

May 7, 2024, 10:33 PM EDT - 1 year ago

Penumbra, Inc. (PEN) Q1 2024 Earnings Call Transcript

Penumbra, Inc. Reports First Quarter 2024 Financial Results

May 7, 2024, 4:05 PM EDT - 1 year ago

Penumbra, Inc. Reports First Quarter 2024 Financial Results

Penumbra, Inc. to Present at the RBC Capital Markets Global Healthcare Conference

May 1, 2024, 4:05 PM EDT - 1 year ago

Penumbra, Inc. to Present at the RBC Capital Markets Global Healthcare Conference

Penumbra Launches Lightning Flash 2.0 - Latest CAVT Technology Designed to Rapidly Remove Blood Clots

Apr 23, 2024, 9:00 AM EDT - 1 year ago

Penumbra Launches Lightning Flash 2.0 - Latest CAVT Technology Designed to Rapidly Remove Blood Clots

Penumbra, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024

Apr 9, 2024, 4:05 PM EDT - 1 year ago

Penumbra, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024

10 Companies To Watch In Q2 2024

Apr 2, 2024, 11:44 PM EDT - 1 year ago

10 Companies To Watch In Q2 2024

CRM OSK TMHC

Penumbra, Inc. (PEN) Q4 2023 Earnings Call Transcript

Feb 22, 2024, 8:55 PM EST - 1 year ago

Penumbra, Inc. (PEN) Q4 2023 Earnings Call Transcript

Penumbra, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results

Feb 22, 2024, 4:05 PM EST - 1 year ago

Penumbra, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results

Penumbra, Inc. Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for February 22, 2024

Feb 1, 2024, 4:05 PM EST - 1 year ago

Penumbra, Inc. Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for February 22, 2024

Penumbra, Inc. to Present at the J.P. Morgan 42nd Annual Healthcare Conference

Dec 18, 2023, 7:50 PM EST - 1 year ago

Penumbra, Inc. to Present at the J.P. Morgan 42nd Annual Healthcare Conference

First Patient in STORM-PE RCT Enrolled Evaluating Penumbra's Latest Computer Assisted Vacuum Thrombectomy - Lightning Flashâ„¢ - for Treatment of Acute Pulmonary Embolism

Nov 28, 2023, 9:00 AM EST - 1 year ago

First Patient in STORM-PE RCT Enrolled Evaluating Penumbra's Latest Computer Assisted Vacuum Thrombectomy - Lightning Flashâ„¢ - for Treatment of Acute Pulmonary Embolism

yaydeezie
yaydeezie Jul. 11 at 2:58 PM
$PEN why is this stock dropping? 👀🙄
0 · Reply
JarvisFlow
JarvisFlow Jul. 9 at 7:17 PM
Citigroup has updated their rating for Penumbra ( $PEN ) to Neutral with a price target of 285.
0 · Reply
NVDAMillionaire
NVDAMillionaire Jul. 7 at 11:32 AM
$PEN Excellent article that nails exactly where PEN stands right now. So if you want to update your PEN knowledge or get acquainted with PEN, this is a must read. https://beyondspx.com/article/penumbra-cavt-innovation-fuels-growth-and-profitability-expansion-nyse-pen
0 · Reply
JarvisFlow
JarvisFlow Jun. 20 at 10:30 AM
RBC Capital updates rating for Penumbra ( $PEN ) to Outperform, target set at 232 → 285.
0 · Reply
JarvisFlow
JarvisFlow Jun. 20 at 10:30 AM
RBC Capital has updated their rating for Penumbra ( $PEN ) to Outperform with a price target of 232.
0 · Reply
StreetwiseReports
StreetwiseReports Jun. 17 at 9:32 PM
Exploration Firms Seize Opportunity Amid Global Oil Reset https://ow.ly/gQLs50Wb8fA Jericho Energy Ventures Inc., Panoro Energy ASA, and Ring Energy Inc. pursue bold strategies to unlock value from powering AI data centers to boosting reserves and expanding U.S. shale production. Read more to see how each company is adapting to shifting oil market dynamics and long-term energy trends. $JEV.V $JROOF $PEN:OSE $REI
0 · Reply
Looking4Bargain
Looking4Bargain Jun. 14 at 7:37 PM
$PEN Price keeps this way I see this as a ~$320 buyout. Same fate as $SWAV.
0 · Reply
ZacksResearch
ZacksResearch Jun. 9 at 2:55 PM
$PEN launches Ruby XL System — what’s next for the stock? PEN is expanding its peripheral embolization portfolio with the Ruby XL System, aiming to enhance efficiency and outcomes while reducing radiation exposure. The positive market sentiment is expected to continue with PEN's anticipated 67.6% earnings increase by 2025 according to the Zacks Consensus Estimate. Discover more about PEN's growth potential here 👉 https://www.zacks.com/commentary/2490510/pen-stock-rises-following-the-launch-of-ruby-xl-system?cid=sm-stocktwits-2-2490510-body&ADID=SYND_STOCKTWITS_TWEET_2_2490510_BODY
0 · Reply
ZacksResearch
ZacksResearch Jun. 9 at 12:07 PM
$PEN pops on new product launch — is this the next growth driver? The FDA-cleared Ruby XL System brings advanced coil tech to high-flow embolization, expanding Penumbra’s vascular solutions lineup. Full breakdown of the launch here 👉 https://www.zacks.com/stock/news/2490510/pen-stock-rises-following-the-launch-of-ruby-xl-system?cid=sm-stocktwits-2-2490510-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2490510_TEASER
0 · Reply
TalkMarkets
TalkMarkets Jun. 8 at 7:20 PM
3 Medical Instruments Stocks Winning Big With GenAI Amid Global Gloom $ANGO $ITGR $PEN https://talkmarkets.com/content/stocks--equities/3-medical-instruments-stocks-winning-big-with-genai-amid-global-gloom?post=501843&userid=123969
0 · Reply
yaydeezie
yaydeezie Jun. 4 at 2:32 PM
$PEN why is this stock going down?
1 · Reply
Looking4Bargain
Looking4Bargain May. 29 at 5:33 AM
$PEN Next earnings it will go $315. I still strongly feel this is a buy out candidate for a big company.
0 · Reply
ZacksResearch
ZacksResearch May. 22 at 10:53 AM
$PEN has shown notable strength over the past year, driven by the performance of its core U.S. thrombectomy business. Solid international prospects instill optimism. Explore further: https://www.zacks.com/stock/news/2475792/penumbra-rallies-359-in-a-year-whats-driving-the-stock?cid=sm-stocktwits-2-2475792-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2475792_TEASER
0 · Reply
StockMusic
StockMusic May. 15 at 3:28 PM
$PEN why the sell off?
1 · Reply
tmcLikeAndSubscribe
tmcLikeAndSubscribe May. 13 at 7:51 PM
Why no go $PEN
0 · Reply
PubCoInsight_
PubCoInsight_ May. 13 at 12:41 PM
💰 Don’t let the fear mongers keep you on the sidelines. The market is rewarding companies with earnings, innovation, and resilience. Take note of the leaders breaking out right now! 🚀 Read the full article: https://pubcoinsight.com/5-stocks-beating-wall-street-at-its-own-game-and-why-the-recession-crowd-got-it-all-wrong/ $PEN $SCHW $BSX $TJX $MELI #StockMarket #Investing #Growth
0 · Reply
Stoop_Kid
Stoop_Kid May. 10 at 4:16 PM
$TTAM $SLVM $PEN $HSY outta the blocks GDDY up and GRND
0 · Reply
blacknred
blacknred May. 10 at 1:24 PM
$PEN Rodger is an economist letting everybody know on here that pen isn’t a good investment here some of his history
0 · Reply
abubnic
abubnic May. 9 at 7:46 PM
$PEN on IBD Institutional Buy List today. Stock is up following comments made by a Piper Sandler analyst who suggested indications that the company's sales force for Thunderbolt is gearing up for product demonstrations. He anticipates that Thunderbolt may receive FDA approval earlier than anticipated and possibly within the next few weeks, rather than later in the year as previously indicated.
1 · Reply
Grouphome
Grouphome May. 9 at 3:00 PM
$PEN
0 · Reply
StreetwiseReports
StreetwiseReports May. 8 at 6:39 PM
Energy Co. Produces 12,000 Barrels of Oil Per Day in Q1/25: https://ow.ly/K4h650VPv6j Forecasted total cash flow through 2027 is sufficient to support continued shareholder dividends, noted Auctus Advisors in a report. $PEN:OSE Panoro Energy ASA
0 · Reply
G_krupins
G_krupins May. 4 at 1:20 PM
$PEN like this setup coming into next week
0 · Reply